Published in Ann Thorac Surg on May 01, 2005
Aortitis. Circulation (2008) 3.60
Insights into imaging of aortitis. Insights Imaging (2012) 1.08
Refractory PMR with aortitis: life-saving treatment with anti-IL6 monoclonal antibody (tocilizumab) and surgical reconstruction of the ascending aorta. BMJ Case Rep (2013) 0.78
Combined medical, surgical and endovascular treatment of a giant cell arteritis case manifesting as upper limbs acute ischemia. Int J Surg Case Rep (2011) 0.75
Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med (2007) 6.00
Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med (2005) 4.84
Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets. JAMA (2013) 4.69
2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2008) 3.70
Surgical treatment of cardiac papillary fibroelastoma: a single center experience with eighty-eight patients. Ann Thorac Surg (2005) 3.38
Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation (2002) 3.25
Valvular heart disease in patients taking pergolide. Mayo Clin Proc (2002) 3.00
Cardiopulmonary bypass during pregnancy. Ann Thorac Surg (2011) 2.81
Malignant primary cardiac tumors: review of a single institution experience. Cancer (2008) 2.59
Acute aortic dissection: population-based incidence compared with degenerative aortic aneurysm rupture. Mayo Clin Proc (2004) 2.55
Variability in data: the Society of Thoracic Surgeons National Adult Cardiac Surgery Database. J Thorac Cardiovasc Surg (2010) 2.51
2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol (2008) 2.46
Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol (2005) 2.43
Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation (2008) 2.42
Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in the current era. Ann Thorac Surg (2006) 2.39
Effectiveness of dabigatran etexilate for thromboprophylaxis of mechanical heart valves. J Thorac Cardiovasc Surg (2011) 2.24
Aortic dissection in pregnancy: analysis of risk factors and outcome. Ann Thorac Surg (2003) 2.23
Quality of life after early mitral valve repair using conventional and robotic approaches. Ann Thorac Surg (2012) 2.15
Mycotic aneurysms of the thoracic aorta: a diagnostic challenge. Am J Med (2003) 2.15
Ministernotomy versus conventional sternotomy for aortic valve replacement: a systematic review and meta-analysis. J Thorac Cardiovasc Surg (2008) 2.06
Iatrogenic cardiac papillary fibroelastoma: a study of 12 cases (1990 to 2000). Hum Pathol (2002) 2.06
Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation (2003) 2.01
Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation (2002) 2.00
Double-orifice left atrioventricular valve in patients with atrioventricular septal defects: surgical strategies and outcome. Ann Thorac Surg (2012) 1.97
Mediastinal paragangliomas: the mayo clinic experience. Ann Thorac Surg (2008) 1.95
Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol (2007) 1.91
Surgical management of anomalous aortic origin of a coronary artery. Ann Thorac Surg (2009) 1.90
Ten-year experience with the Cox-maze procedure for atrial fibrillation: how do we define success? Ann Thorac Surg (2007) 1.88
Completion pericardiectomy for recurrent constrictive pericarditis: importance of timing of recurrence on late clinical outcome of operation. Ann Thorac Surg (2012) 1.86
Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications. J Am Coll Cardiol (2002) 1.85
Identifying patients at particular risk of injury during repeat sternotomy: analysis of 2555 cardiac reoperations. J Thorac Cardiovasc Surg (2010) 1.82
Thoracoscopic versus open mitral valve repair: a propensity score analysis of early outcomes. Ann Thorac Surg (2009) 1.78
Validation of clinical scores predicting severe acute kidney injury after cardiac surgery. Am J Kidney Dis (2010) 1.75
Surgical correction of mitral regurgitation in the elderly: outcomes and recent improvements. Circulation (2006) 1.73
Long-term risk of aortic events following aortic valve replacement in patients with bicuspid aortic valves. Am J Cardiol (2010) 1.72
Importance of implant technique on risk of major paravalvular leak (PVL) after St. Jude mechanical heart valve replacement: a report from the Artificial Valve Endocarditis Reduction Trial (AVERT). Eur J Cardiothorac Surg (2005) 1.68
Transient constrictive pericarditis: causes and natural history. J Am Coll Cardiol (2004) 1.68
Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery. Crit Care (2011) 1.67
Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc (2005) 1.62
Evaluation of a novel 2 mm internal diameter stainless steel saphenous vein to coronary artery connector: laboratory studies of on-pump and off-pump revascularization. Eur J Cardiothorac Surg (2003) 1.60
Survival after resection of primary cardiac tumors: a 48-year experience. Circulation (2008) 1.60
Aortic root enlargement: what are the operative risks? J Thorac Cardiovasc Surg (2007) 1.59
Aortic valve replacement in patients aged 50 to 70 years: improved outcome with mechanical versus biologic prostheses. J Thorac Cardiovasc Surg (2008) 1.56
Metastatic carcinoid tumor to the heart: echocardiographic-pathologic study of 11 patients. J Am Coll Cardiol (2002) 1.56
Systolic anterior motion after mitral valve repair: is surgical intervention necessary? J Thorac Cardiovasc Surg (2006) 1.55
Superiority of cut-and-sew technique for the Cox maze procedure: comparison with radiofrequency ablation. J Thorac Cardiovasc Surg (2007) 1.54
Prognosis of carcinoid heart disease: analysis of 200 cases over two decades. Circulation (2005) 1.53
Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy. Eur Heart J (2007) 1.53
Recurrent mitral regurgitation after repair: should the mitral valve be re-repaired? J Thorac Cardiovasc Surg (2006) 1.53
Selection of aortic valve prostheses: contemporary reappraisal of mechanical versus biologic valve substitutes. Circulation (2013) 1.52
Fifty years of open heart surgery at the Mayo Clinic. Mayo Clin Proc (2005) 1.52
The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol (2004) 1.52
American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr (2013) 1.51
Safety of same-day coronary angiography in patients undergoing elective aortic valve replacement. Ann Thorac Surg (2011) 1.51
Left atrial ganglion ablation as an adjunct to atrial fibrillation surgery in valvular heart disease. Ann Thorac Surg (2011) 1.51
Robotic mitral valve repair for all prolapse subsets using techniques identical to open valvuloplasty: establishing the benchmark against which percutaneous interventions should be judged. J Thorac Cardiovasc Surg (2011) 1.51
Influence of preoperative lipid-lowering therapy on postoperative outcome in patients undergoing coronary artery bypass grafting. Am J Cardiol (2007) 1.50
Accuracy of roche accu-chek inform whole blood capillary, arterial, and venous glucose values in patients receiving intensive intravenous insulin therapy after cardiac surgery. Am J Clin Pathol (2007) 1.48
Spectrum and outcome of reoperations after the Ross procedure. Circulation (2010) 1.47
Increased risk of acute kidney injury in patients undergoing tricuspid valve surgery. Eur J Cardiothorac Surg (2012) 1.45
The modified Fontan procedure: early and late results in 132 adult patients. J Thorac Cardiovasc Surg (2003) 1.45
Surgery for aneurysms of the aortic root: a 30-year experience. Circulation (2004) 1.45
Intermediate-term results of ascending-descending posterior pericardial bypass of complex aortic coarctation. J Thorac Cardiovasc Surg (2007) 1.44
A prospective, randomized comparison of 3 contemporary bioprosthetic aortic valves: should hemodynamic performance influence device selection? J Thorac Cardiovasc Surg (2012) 1.44
Surgery insight: Septal myectomy for obstructive hypertrophic cardiomyopathy--the Mayo Clinic experience. Nat Clin Pract Cardiovasc Med (2007) 1.41
What is the optimal myocardial preservation strategy at re-operation for aortic valve replacement in the presence of a patent internal thoracic artery? Eur J Cardiothorac Surg (2011) 1.40
Improving results of open arch replacement. Ann Thorac Surg (2008) 1.39